Virus World
379.7K views | +3 today
Follow
Virus World
Virus World provides a daily blog of the latest news in the Virology field and the COVID-19 pandemic. News on new antiviral drugs, vaccines, diagnostic tests, viral outbreaks, novel viruses and milestone discoveries are curated by expert virologists. Highlighted news include trending and most cited scientific articles in these fields with links to the original publications. Stay up-to-date with the most exciting discoveries in the virus world and the last therapies for COVID-19 without spending hours browsing news and scientific publications. Additional comments by experts on the topics are available in Linkedin (https://www.linkedin.com/in/juanlama/detail/recent-activity/)
Curated by Juan Lama
Your new post is loading...
Scooped by Juan Lama
Scoop.it!

Why We Can Thank a Polio Emergency for the Birth of Intensive Care - Nature

Why We Can Thank a Polio Emergency for the Birth of Intensive Care - Nature | Virus World | Scoop.it

An outbreak of polio in 1950s Denmark led one hospital to pioneer mechanical ventilation, constant monitoring of vital signs and other innovations that are saving lives to this day. The COVID-19 pandemic has brought home the central role of intensive care units (ICUs) in saving the lives of those in critical condition in hospitals today. Yet if you asked most people where the ICU concept came from, few would know that it was an outgrowth of a polio epidemic in Denmark. In her brilliant new book, Hannah Wunsch, an anaesthesiologist and critical-care-medicine specialist at the University of Toronto, Canada, traces the origins of the modern ICU to 1952 and the Blegdam hospital in Copenhagen — something she has written about before in Nature (go.nature.com/45B6snd). There, a series of innovations arose out of dire need, including positive-pressure ventilation (the precursor to mechanical ventilators), blood-gas measurements for pH and carbon-dioxide levels and close monitoring by an interdisciplinary team of nurses, doctors (notably anaesthesiologists), pharmacists and others. The treatment of one patient, a 12-year-old girl named Vivi Ebert who presented with bulbar paralytic poliomyelitis — in which poliovirus infects the brainstem — forms the centrepiece of Wunsch’s book. Of the first 31 people to be admitted to the Blegdam in the summer of 1952 with paralytic or respiratory polio symptoms, 87% died, 70% within three days. Thanks to interventions including manual ventilation, supervised by anaesthesiologist Bjørn Ibsen, Ebert survived another twenty years, eventually succumbing to pneumonia at the age of 32.

 

In those early days it took 50 people to provide the muscle power required for round-the-clock ventilation for 6–8 people with paralytic polio. The hospital’s initial success led to more than 1,500 medical and dental students being employed as manual ventilators for patients admitted in the summer and autumn of 1952. Eventually, ‘iron lungs’ — mechanical ventilator machines — took the place of humans, and the ICU concept was built, focusing on the sickest patients, who required a breathing machine and constant monitoring. Over the next few years, the use of ICUs expanded to the treatment of people with major trauma, shock, tetanus and a variety of other acute, life-threatening conditions. The treatment of polio, the main story of The Autumn Ghost, has rich parallels to the COVID-19 pandemic. In the 1950s, the prevailing hypothesis about the spread of polio was that the virus was inhaled into the body’s upper airways. It took decades for the gastrointestinal transmission route — oral contact with the faeces of an infected person — to become accepted. Similarly, for COVID-19, there was an initial fixation on liquid droplets on surfaces and in the air as the main means of transmission, whereas it was determined later that it was spread predominantly within tiny droplets or aerosols in the air. Furthermore, a substantial proportion of both poliovirus and SARS-CoV-2 infections were asymptomatic. And both viruses have long-term consequences: for polio, not only potential paralysis, but also the debilitating neuromuscular syndrome that can occur decades later. Long COVID affects 10–12% of infected individuals, with a variety of enduring symptoms that can be incapacitating with potentially more longer-term effects that are yet unknown.

 

Polio taught us about the efficacy of positive-pressure ventilation for those having difficulty with breathing. With COVID-19, we learnt that ventilating patients while they were lying face down was crucial to good outcomes. For poliovirus, large, randomized trials of γ-globulin — a substance derived from bone marrow and lymph gland cells containing antibodies thought to help fight the virus — had some success in the years before a vaccine became available. For COVID-19, large observational studies were undertaken of treatment with blood plasma from those who had recovered, although a lack of randomized studies makes it hard to assess the treatment’s effectiveness. Perhaps the most striking difference between the two viruses is how long it was before a vaccine was developed. For SARS-CoV-2, it was 10 months from sequencing the virus to producing results from large, randomized trials demonstrating high levels of vaccine efficacy. Large-scale distribution quickly followed. Poliovirus was identified as the pathogen for polio in 1908, but it wasn’t until 1955 that US virologist Jonas Salk developed the first effective vaccine to be delivered by means of an injection, followed quickly by an oral vaccine developed by US physician and microbiologist Albert Sabin in 1961.

 

Wunsch provides a detailed history of polio, the iron lung, the rise of the field of anaesthesiology, the development of the Salk and Sabin vaccines and the work at Denmark’s Statens Serum Institute, a medical laboratory in Copenhagen, in manufacturing and rolling out the Salk vaccine ten days after it was announced. But she really hits her stride when she describes those whose lives were saved. Another early patient treated by tracheostomy and hand ventilation at the Blegdam hospital was 26-year-old Rosa Abrahamsen. She was a poet, and her beautiful poems, translated into English for the book, begin several chapters. The Autumn Ghost might have been improved with a timeline, given that it bounces back and forth at many points. Although the extraordinary progress and innovations made in Denmark were central to the development of ICUs, the contribution of parallel efforts from around the world might not have been adequately highlighted. When I was at the University of Virginia in Charlottesville in the 1970s, I worked as a respiratory technician on the night shift, maintaining Engström ventilators (alluded to in the book as the “Rolls Royce of artificial respiration”) for patients in the ICU. I had no idea how those ventilators, or indeed ICUs, came to be. But seeing many patients ‘come back to life’ inspired me to go to medical school. Only five decades later, thanks to reading this book, have I learned the remarkable background to these profound innovations — and how the poliovirus radically transformed the future of medicine.

No comment yet.
Scooped by Juan Lama
Scoop.it!

Can Existing Live Vaccines Prevent COVID-19? 

Can Existing Live Vaccines Prevent COVID-19?  | Virus World | Scoop.it

Prophylactic vaccination is the most effective intervention to protect against infectious diseases. The commonly accepted paradigm is that immunization with both attenuated virus (live but with substantially reduced virulence) and inactivated (killed virus particles) vaccines induces adaptive and generally long-term and specific immunity in the form of neutralizing antibodies and/or activating pathogen-specific cellular immune responses. However, an increasing body of evidence suggests that live attenuated vaccines can also induce broader protection against unrelated pathogens likely by inducing interferon and other innate immunity mechanisms that are yet to be identified. The stimulation of innate immunity by live attenuated vaccines in general, and oral poliovirus vaccine (OPV) in particular, could provide temporary protection against coronavirus disease 2019 (COVID-19).

 

OPV was developed by Albert Sabin in the 1950s and consists of live attenuated polioviruses of the three serotypes. Early clinical studies showed that besides protecting against poliomyelitis, OPV reduced the number of other viruses that could be isolated from immunized children, compared with placebo recipients. Additional evidence of nonspecific effects of OPV came from the 1959 poliomyelitis outbreak in Singapore caused by type 1 poliovirus that was successfully stopped by the use of monovalent OPV that contained only type 2 poliovirus (1). Monovalent OPVs do not induce cross-neutralizing antibodies that target other virus serotypes, so the most plausible explanation was viral interference, which presumably is mediated by innate immunity.

 

Large-scale clinical studies of OPV for nonspecific prevention of diseases were carried out in the 1960s and 1970s. These involved more than 60,000 individuals and showed that OPV was effective against influenza virus infection, reducing morbidity 3.8-fold on average (23). OPV vaccination also had a therapeutic effect on genital herpes simplex virus infections, accelerating healing. OPV not only demonstrated positive effects against viral infections but also had oncolytic properties, both by directly destroying tumor cells and by activating cellular immunity toward tumors (2). These observations were among the first examples of viral oncotherapy, which is being actively pursued.

 

Published in Science (June 12, 2020):

https://doi.org.10.1126/science.abc4262

No comment yet.
Scooped by Juan Lama
Scoop.it!

Slowing the Coronavirus Is Speeding the Spread of Other Diseases - The New York Times

Slowing the Coronavirus Is Speeding the Spread of Other Diseases - The New York Times | Virus World | Scoop.it

Many mass immunization efforts worldwide were halted this spring to prevent spread of the virus at crowded inoculation sites. The consequences have been alarming. As poor countries around the world struggle to beat back the coronavirus, they are unintentionally contributing to fresh explosions of illness and death from other diseases — ones that are readily prevented by vaccines. This spring, after the World Health Organization and UNICEF warned that the pandemic could spread swiftly when children gathered for shots, many countries suspended their inoculation programs. Even in countries that tried to keep them going, cargo flights with vaccine supplies were halted by the pandemic and health workers diverted to fight it.

 

Now, diphtheria is appearing in Pakistan, Bangladesh and Nepal.

Cholera is in South Sudan, Cameroon, Mozambique, Yemen and Bangladesh. A mutated strain of poliovirus has been reported in more than 30 countries. And measles is flaring around the globe, including in Bangladesh, Brazil, Cambodia, Central African Republic, Iraq, Kazakhstan, Nepal, Nigeria and Uzbekistan. Of 29 countries that have currently suspended measles campaigns because of the pandemic, 18 are reporting outbreaks. An additional 13 countries are considering postponement. According to the Measles and Rubella Initiative, 178 million people are at risk of missing measles shots in 2020. The risk now is “an epidemic in a few months’ time that will kill more children than Covid,” said Chibuzo Okonta, the president of Doctors Without Borders in West and Central Africa.

 

As the pandemic lingers, the W.H.O. and other international public health groups are now urging countries to carefully resume vaccination while contending with the coronavirus. At stake is the future of a hard-fought, 20-year collaboration that has prevented 35 million deaths in 98 countries from vaccine-preventable diseases, and reduced mortality from them in children by 44 percent, according to a 2019 study by the Vaccine Impact Modeling Consortium, a group of public health scholars...

No comment yet.